By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Edge Therapeutics 

NJIT-EDC Biotechnology Incubator
139 South Street, Suite 102
New Providence  New Jersey  07974  U.S.A.
Phone: 800-208-EDGE Fax: 800-208-3433


SEARCH JOBS


Industry
Biotechnology






Company News
Edge Therapeutics Reports Second Quarter 2017 Financial Results And Continued Operational Progress 8/1/2017 1:09:40 PM
Edge Therapeutics Announces Second Quarter Financial Results Conference Call On August 1, 2017 7/18/2017 10:43:07 AM
Edge Therapeutics Receives Pediatric Investigation Plan Waiver From The EMA 6/8/2017 11:04:18 AM
Edge Therapeutics Reports First Quarter 2017 Financial Results And Continued Operational Progress 5/3/2017 10:55:13 AM
Edge Therapeutics Announces Conference Call On May 3, 2017 To Discuss First Quarter 2017 Financial Results 4/21/2017 8:19:44 AM
Edge Therapeutics Announces $18 Million Registered Direct Offering Of Common Stock 4/19/2017 8:39:26 AM
Edge Therapeutics Announces First Patient Randomized In Study Of Intracisternal Administration Of EG-1962 In Adults With Aneurysmal Subarachnoid Hemorrhage 3/13/2017 8:26:48 AM
Edge Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results 3/2/2017 9:03:45 AM
Edge Therapeutics Announces Conference Call On March 2, 2017 To Discuss Fourth Quarter And Full Year 2016 Financial Results 2/23/2017 11:17:27 AM
Edge Therapeutics Appoints Alyssa Wyant As Senior Vice President, Regulatory Affairs And Makes Inducement Grant Under NASDAQ Rule 5635(C)(4) 2/21/2017 10:55:22 AM
123456
//-->